The State of Cannabis Research Legislation in 2020.
作者信息
Zarrabi Ali J, Frediani Jennifer K, Levy Joshua M
机构信息
From the Division of Palliative Medicine, Department of Family and Preventive Medicine (A.J.Z.), and the Department of Otolaryngology-Head and Neck Surgery (J.M.L.), Emory University School of Medicine, and the Nell Hodgson Woodruff School of Nursing, Emory University (J.K.F.) - both in Atlanta.
出版信息
N Engl J Med. 2020 May 14;382(20):1876-1877. doi: 10.1056/NEJMp2003095.
Abstract
摘要
相似文献
1
The State of Cannabis Research Legislation in 2020.2020年大麻研究立法状况
N Engl J Med. 2020 May 14;382(20):1876-1877. doi: 10.1056/NEJMp2003095.
2
The Need for Federal Regulation of Marijuana Marketing.联邦对大麻营销进行监管的必要性。
JAMA. 2019 Jun 11;321(22):2163-2164. doi: 10.1001/jama.2019.4432.
3
The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.首个获美国食品药品监督管理局批准的大麻衍生疗法之路及后续发展。
JAMA. 2018 Sep 25;320(12):1227-1229. doi: 10.1001/jama.2018.11914.
4
Should Physicians Recommend Replacing Opioids With Cannabis?医生应该建议用大麻替代阿片类药物吗？
JAMA. 2019 Feb 19;321(7):639-640. doi: 10.1001/jama.2019.0077.
5
Medical Board Expectations for Physicians Recommending Marijuana.医学委员会对推荐大麻的医生的期望。
JAMA. 2016 Aug 9;316(6):577-8. doi: 10.1001/jama.2016.7741.
6
Behind Schedule - Reconciling Federal and State Marijuana Policy.进度滞后——协调联邦与州的大麻政策
N Engl J Med. 2018 Aug 9;379(6):501-504. doi: 10.1056/NEJMp1804408. Epub 2018 Jul 11.
7
Medical Marijuana: Is the Cart Before the Horse?医用大麻：本末倒置了吗？
JAMA. 2015;313(24):2431-2. doi: 10.1001/jama.2015.6407.
8
Petition against "cruel" and "ridiculous" guidance on access to medicinal cannabis attracts 400 000 signatures.反对获取医用大麻的“残忍”且“荒谬”指导方针的请愿书获得了40万个签名。
BMJ. 2018 Nov 15;363:k4833. doi: 10.1136/bmj.k4833.
9
CMA position against separate regulations for medical cannabis draws ire and insults.美国管理会计师协会反对医用大麻单独监管的立场引发了愤怒和辱骂。
CMAJ. 2018 May 7;190(18):E574-E575. doi: 10.1503/cmaj.109-5594.
10
Medical cannabis: time for clear thinking.医用大麻：是时候进行清晰思考了。
Med J Aust. 2015 Feb 2;202(2):74-5. doi: 10.5694/mja14.01573.
引用本文的文献
1
Is it time for a cannabis harm reduction approach? Commentary on Sherman et al. (2022) and Borodovsky et al. (2022).是否是时候采取大麻危害减少措施了？对 Sherman 等人（2022 年）和 Borodovsky 等人（2022 年）的评论。
Psychol Addict Behav. 2023 Aug;37(5):709-712. doi: 10.1037/adb0000927.
2
Between Science and Big Business: Tapping Mary Jane's Uncharted Potential.在科学与大企业之间：挖掘大麻的未知潜力。
ACS Cent Sci. 2022 Feb 23;8(2):156-168. doi: 10.1021/acscentsci.1c01100. Epub 2022 Jan 26.
3
"I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums.“我抽了很多大麻来帮助我度过戒断期”：在网上阿片类药物和阿片类药物康复社区讨论论坛上报告了自然主义大麻使用情况。
PLoS One. 2022 Feb 8;17(2):e0263583. doi: 10.1371/journal.pone.0263583. eCollection 2022.
4
The National Cancer Institute and Cannabis and Cannabinoids Research.美国国家癌症研究所与大麻及大麻素研究
J Natl Cancer Inst Monogr. 2021 Nov 28;2021(58):35-38. doi: 10.1093/jncimonographs/lgab014.
Zotero 插件